| Literature DB >> 19693767 |
Ramesh P Thylur1, Young-Dae Kim, Min-Sung Kwon, Hyun-Mee Oh, Ho-Keun Kwon, Sang-Hyun Kim, Sin-Hyeog Im, Jang-Soo Chun, Zee-Yong Park, Chang-Duk Jun.
Abstract
Swiprosin-1 exhibits the highest expression in CD8(+) T cells and immature B cells and has been thought to play a role in lymphocyte physiology. Here we report that swiprosin-1 is also expressed in mast cells and up-regulated in both in vitro cultured mast cells by phorbol ester and in vivo model tissues of passive cutaneous anaphylaxis and atopic dermatitis. Targeted inhibition of the specific protein kinase C (PKC) isotypes by siRNA revealed that PKC-beta I/eta are involved in the expression of swiprosin-1 in the human mast cell line HMC-1. In contrast, down-regulation of swiprosin-1 by A23187 or ionomycin suggests that calcium-signaling plays a negative role. The ectopic expression of swiprosin-1 augmented PMA/A23187-induced NF-kappaB promoter activity, and resulted in increased expression of cytokines. Moreover, knock-down of swiprosin-1 attenuated PMA/A23187-induced cytokine expression. Collectively, these results suggest that swiprosin-1 is a PKC-beta I/eta-inducible gene and it modulates mast cell activation through NF-kappaB-dependent pathway. (c) 2009 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19693767 DOI: 10.1002/jcb.22307
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429